Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants

Nov 25, 2019, 01:45 PM
The Stock Day Podcast welcomed Biostage, Inc. (BSTG)(“the Company”), a bioengineering company that is developing next-generation esophageal implants. CEO of the Company, Jim McGorry, joined Stock Day host Everett Jolly.